Editorial

Clin Osteol 2020; 25(3): 106

How to treat a diabetic patient with osteoporosis

Jackuliak Peter; Kovářová Magdaléna; Kužma Martin; Killinger Zdenko; Payer Juraj

Clin Osteol 2020; 25(3): 107-114

Diabetes mellitus and osteoporosis are two serious civilization diseases with increasing incidence. Osteoporosis and osteoporotic fractures are already accepted as a severe co-morbidity and complications of diabetes mellitus. In management of diabetic patients is necessary to identify the high-risk group for osteoporosis and fractures, and to take appropriate preventive and therapeutic options. Available antiresorptive and osteoanabolic drug agents, which are used to treat osteoporosis, are effective also in diabetes patients. Most of the data of their effects in dia­betics come only from clinical practice. But it is also necessary to achieve optimal...

Selected biomarkers associated with atherosclerosis and bone metabolism

Demková Katarína; Tkáč Ivan

Clin Osteol 2020; 25(3): 115-119

Atherosclerosis is characterized by persistent inflammation of the vascular wall and is considered to be a major cause contributing to the development of cardiovascular disease, which is the leading cause of death worldwide. Due to the prevalence of atherosclerosis and its complications, the need for early and, if possible, non-invasive dia­gnosis is increasing in order to prevent the development of fatal or disabling complications of atherosclerosis. Ima­ging methods as well as clinical examinations are used for the detection of atherosclerotic plaques, which capture up to hemodynamically significant plaques. Better prevention of atherosclerosis requires...

Ukrajinská verzia FRAX pre posúdenie rizika zlomenín u žien s reumatoidnou artritídou

Povoroznyuk Vladyslav, Grygorieva Nataliia, Ivanik Oksana, Bystrytska Maryna, Dzerovych Nataliia, Povorozniuk Vasyl, Musiienko Anna, Zaverukha Nataliia

Clin Osteol 2020; 25(3): 120-127

Neurogenic heterotopic ossification

Oc K Ján

Clin Osteol 2020; 25(3): 128-134

Neurogenic heterotopic ossification (NHO) is a complication affecting one in five patients after a spinal cord injury or traumatic brain injury. It leads to severe pain, loss of range of motion, as the joint gradually becomes ankylosed, leading to greater functional disability. The etiopathogenesis and risk factors of NHO remain poorly understood. The aim of this review was to focus on advances in the understanding of the underlying mechanisms of NHO, and possible options for the diagnosis, prevention and treatment of NHO.

Klinická osteológia - certifikovaná pracovná činnosť

Payer Juraj; Jackuliak Peter; Killinger Zdenko

Clin Osteol 2020; 25(3): 135-136

23. kongres slovenských a českých osteológov s medzinárodnou účasťou 17.-19. 9. 2020 | Double Tree by Hilton | Bratislava

Clin Osteol 2020; 25(3): 146-168